Likang gets trial ok for China’s first personalized cancer vaccine
Likang Life Sciences has received implied approval for the clinical trial of its personalized neoantigen-targeted…
March 17, 2023 - 3 minutes
T-cells
Beyond Biotech podcast 35: Rare Disease Day
As February 28 is Rare Disease Day, we have three guests on the podcast today…
February 24, 2023 - 3 minutes
Positive results for INOVIO recurrent respiratory papillomatosis trial
INOVIO Pharmaceuticals has announced positive preliminary results from the second cohort of its phase 1/2…
February 17, 2023 - 3 minutes
Genetic study reveals high variation in T-cell receptor genes
T-cells are central in the protection against infections and cancer. With the help of TCRs…
February 16, 2023 - 3 minutes
Scancell looking to partner after positive COVID vaccine data
Scancell Holdings plc, which develops novel immunotherapies for the treatment of cancer and infectious disease,…
February 14, 2023 - 5 minutes
Syena created to deliver first-in-class TCR-NK cell therapy
Replay, a genome writing company reprogramming biology by writing and delivering big DNA, and The…
February 14, 2023 - 4 minutes
HKUMed uncovers T cell exhaustion factor driving cancer immunotherapy resistance
A research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed)…
January 27, 2023 - 2 minutes
First leukemia patient dosed with SMART101
Smart Immune has announced that the first adult leukemia patient has been dosed with SMART101,…
January 24, 2023 - 2 minutes
Legend Biotech new drug application approved in China
Legend Biotech Corporation has announced that China’s National Medical Products Administration (NMPA) has formally accepted…
January 3, 2023 - 3 minutes
First CAR-T technology trial for patients with T-cell leukemia subtype authorized
The Spanish Agency of Medicines and Medical Products (AEMPS) has approved the CARxALL clinical trial…
December 22, 2022 - 4 minutes
PDC*line Pharma presents first immunological results from trial with PDC*lung01
PDC*line Pharma, a clinical stage biotech company has announced the first immunological results of its…
December 8, 2022 - 3 minutes
Laevoroc Oncology pushes for relapsed leukemia cure
Laevoroc Oncology, a privately-owned, Swiss oncology development company, has announced the publication of key preclinical…
December 8, 2022 - 2 minutes
